Login to Your Account



Omeros' Lead Anti-Inflammatory Drug Moves Into Phase III Study

By Jennifer Boggs


Thursday, April 14, 2005
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription